Spero Therapeutics, Inc.
Ticker: 1701108
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2025 | Q3 FY2024 | Q3 FY2024 | Q2 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.01-85.7% | 0.07+0.0% | 0.07-36.4% | 0.11+0.0% | 0.11-21.4% | 0.14-99.4% | 23.38+2859.5% | 0.79 |
| Total Income | 0.01-85.7% | 0.07+0.0% | 0.07-36.4% | 0.11+0.0% | 0.11-21.4% | 0.14-99.4% | 23.38+2859.5% | 0.79 |
| EXPENSES | ||||||||
| Expenditure | 14.74-21.0% | 18.66+0.0% | 18.66-2.7% | 19.18+0.0% | 19.18+35.8% | 14.12-44.2% | 25.32+85.1% | 13.68 |
| Tax | — | -0.29-200.0% | 0.29 | — | — | — | 2.21 | — |
| PROFIT | ||||||||
| Net Profit | -13.87+19.1% | -17.15+0.0% | -17.15+4.2% | -17.90-0.2% | -17.86-40.6% | -12.70-296.9% | -3.20+73.1% | -11.90 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-91.73pp | -8.27%+91.73pp | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-86.31pp | -13.69%+86.31pp | -100.00% |
| EPS | -0.25+21.9% | -0.32+0.0% | -0.32+3.0% | -0.33+0.0% | -0.33-37.5% | -0.24-300.0% | -0.06+73.9% | -0.23 |
Corporate Events
Board MeetingSPRO
202623Jun
Board Meeting
Annual Meeting of Stockholders where directors were reelecte…
SEC Filing ↗